VA Awards $4.56M for Chemistry-Immunochemistry CPR to Roche Diagnostics, Competition Open
Contract Overview
Contract Amount: $4,558,956 ($4.6M)
Contractor: Roche Diagnostics Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2024-06-01
End Date: 2027-05-31
Contract Duration: 1,094 days
Daily Burn Rate: $4.2K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 4
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: CHEMISTRY-IMMUNOCHEMISTRY CPR
Place of Performance
Location: INDIANAPOLIS, MARION County, INDIANA, 46256
State: Indiana Government Spending
Plain-Language Summary
Department of Veterans Affairs obligated $4.6 million to ROCHE DIAGNOSTICS CORPORATION for work described as: CHEMISTRY-IMMUNOCHEMISTRY CPR Key points: 1. Contract value of $4.56M over 3 years. 2. Roche Diagnostics is the sole awardee. 3. Risk appears low due to established vendor and firm fixed price. 4. Sector is Analytical Laboratory Instrument Manufacturing.
Value Assessment
Rating: good
The contract value of $4.56M for a 3-year period suggests a reasonable annual spend. Benchmarking against similar contracts for analytical laboratory instruments would provide a clearer picture of pricing efficiency.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating a competitive bidding process. This method generally promotes price discovery and ensures fair market pricing.
Taxpayer Impact: The competitive award process is expected to yield fair pricing, maximizing the value of taxpayer funds for essential laboratory equipment.
Public Impact
Ensures continued access to critical diagnostic testing for veterans. Supports the Department of Veterans Affairs' healthcare mission. Potential for innovation and improved diagnostic capabilities through the awarded instrument.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Sole awardee may limit future competitive pricing.
- Dependence on a single vendor for critical supplies.
Positive Signals
- Firm fixed price contract mitigates cost overrun risk.
- Long-term contract provides budget stability.
- Awarded to a known entity with established performance.
Sector Analysis
The Analytical Laboratory Instrument Manufacturing sector is crucial for healthcare diagnostics. Spending benchmarks vary widely based on instrument complexity and volume, but this award appears moderate for specialized equipment.
Small Business Impact
The data indicates no specific set-aside for small businesses. Further analysis would be needed to determine if small businesses were excluded or had no opportunity to compete.
Oversight & Accountability
The contract is managed by the Department of Veterans Affairs, which has established oversight mechanisms for procurement and contract performance. Monitoring delivery and performance against contract terms is key.
Related Government Programs
- Analytical Laboratory Instrument Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Potential for vendor lock-in.
- Reliance on a single supplier for critical medical equipment.
- Limited visibility into specific instrument capabilities from provided data.
- Need for ongoing monitoring of performance and pricing trends.
Tags
analytical-laboratory-instrument-manufac, department-of-veterans-affairs, in, delivery-order, 1m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $4.6 million to ROCHE DIAGNOSTICS CORPORATION. CHEMISTRY-IMMUNOCHEMISTRY CPR
Who is the contractor on this award?
The obligated recipient is ROCHE DIAGNOSTICS CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $4.6 million.
What is the period of performance?
Start: 2024-06-01. End: 2027-05-31.
What is the specific type of chemistry-immunochemistry analyzer being procured, and what are its key capabilities?
The specific analyzer is identified by the National Stock Number 334516, which falls under Analytical Laboratory Instrument Manufacturing. While the data doesn't detail the exact model, these instruments are typically used for complex diagnostic testing in clinical laboratories, performing a range of biochemical and immunological assays critical for patient diagnosis and monitoring.
How does the awarded price compare to market benchmarks for similar analytical laboratory instruments, considering the contract duration and scope?
Without specific model details and a direct comparison to current market pricing for equivalent systems, a precise benchmark is difficult. However, the total contract value of $4.56M over three years, awarded under full and open competition, suggests a potentially competitive price. A deeper dive into the unit cost and service components relative to industry averages is recommended.
What is the potential impact on veteran healthcare if this specific instrument experiences downtime or supply chain disruptions?
Downtime or supply chain disruptions for this critical chemistry-immunochemistry analyzer could significantly impact veteran healthcare by delaying or preventing essential diagnostic tests. This could lead to delayed diagnoses, treatment adjustments, and potentially adverse patient outcomes. Robust service level agreements and contingency plans are vital to mitigate these risks.
Industry Classification
NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing
Product/Service Code: INSTRUMENTS AND LABORATORY EQPT
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Solicitation ID: 36C24724Q0093
Offers Received: 4
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Roche Holding AG
Address: 9115 HAGUE RD, INDIANAPOLIS, IN, 46256
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $7,115,619
Exercised Options: $4,558,956
Current Obligation: $4,558,956
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: V797P7347A
IDV Type: FSS
Timeline
Start Date: 2024-06-01
Current End Date: 2027-05-31
Potential End Date: 2029-05-31 00:00:00
Last Modified: 2026-03-04
More Contracts from Roche Diagnostics Corporation
- THE Purpose of This Contract IS to Procure the Procurement of Over the Counter (OTC) Covid-19 Tests — $90.6M (Department of Health and Human Services)
- Cost PER Test — $13.5M (Department of Veterans Affairs)
- CPT — $5.5M (Department of Veterans Affairs)
- FY22 CPT Chemistry Analyzer — $4.2M (Department of Health and Human Services)
- Visn 19 Chemistry Call Order to Fund Option 3 — $3.6M (Department of Veterans Affairs)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)